Regenstrief Institute, Inc.

A revamped and newly validated symptom assessment tool is helping improve care for nursing home residents with Alzheimer's. As part of the UPLIFT-AD study, researchers, including Regenstrief Institute's Kathleen Unroe, M.D., MHA, M.S., adapted and validated a tool to better assess physical and emotional distress for patients who have difficulty with communication, supporting expanded palliative care efforts in nursing homes. https://lnkd.in/gPpFj24g

Regenstrief Institute celebrates women in leadership who drive innovation, advance research and shape the future of healthcare. We recognize their contributions and commitment to improving health and healthcare for all.

Atrial fibrillation (AFib) often goes undetected until serious complications arise. UNAFIED, an AI-powered risk prediction model developed by researchers including Regenstrief Institute's Randall Grout, M.D., M.S., integrates seamlessly into clinical workflows to help identify at-risk patients early. By leveraging electronic health record data, this tool enables proactive screening, supporting better patient care. Other partners include Eskenazi Health, Pfizer, IU School of Medicine and Franciscan Physician Network https://lnkd.in/gnyWApDX

Regenstrief Institute was well represented at the INSPIRE Benefit, the Alzheimer's Association Greater Indiana Chapter’s signature brunch, alongside influential leaders dedicated to advancing Alzheimer’s and dementia research. The event highlighted the critical work happening in Indianapolis to support caregivers, drive research and shape the future of brain health. Rachel Patzer Nicole Fowler Alexia Torke Susan Hickman Christopher Callahan Malaz Boustani Noll Campbell

A study involving Regenstrief highlights the lack of consensus among experts on continuing vs. discontinuing long-term opioid therapy for chronic pain. The findings emphasize the complexities of pain management and the need for shared decision-making between clinicians and patients. https://lnkd.in/gyYzsqei

Regenstrief Institute, IU School of Medicine and IU Health researchers helped develop a standardized goals of care note in EHRs, making critical patient preference information easier to access. The study highlights how structured documentation improves communication, supports decision-making and enhances end-of-life care. https://lnkd.in/gzk8YKUt

A study team including Regenstrief Institute and IU Indianapolis Fairbanks School of Public Health examines how to better identify emergency department patients with health-related social needs. Researchers found that a machine learning model leveraging electronic health record data was more effective than screening surveys at predicting future needs. Emergency department patients were studied because many of these patients are more likely to fall through the cracks due to lack of comprehensive health insurance, transportation barriers, financial insecurity or not having a doctor to address the condition that brought them to seek care. https://lnkd.in/gRGwQctY

Dr. Clint Cary discusses groundbreaking research for lymph node removal reaffirming the gold standard of care, highlighting the value of high-volume centers, and establishing a benchmark for evaluating new technologies and innovations. https://lnkd.in/gKnZSNNh

Metastatic breast cancer survivors face significant challenges with fatigue, which affects up to 63% of patients. Regenstrief Institute researchers, in collaboration with Indiana University and other partners, found that telephone-delivered acceptance and commitment therapy can reduce fatigue interference and improve quality of life. This novel behavioral intervention, focused on mindfulness and psychological flexibility, also shows promise in improving sleep quality. https://lnkd.in/gcNrkTjc

By integrating palliative care with dementia care, the IN-PEACE study reduced emergency visits and hospitalizations by 50 percent, especially benefiting African American individuals and those with lower incomes. This study published in JAMA highlights the transformative impact of IN-PEACE. Regenstrief’s Greg Sachs, M.D., led the clinical trial along with colleagues from IU School of Medicine. Other partners included IU School of Medicine Division of General Internal Medicine and Geriatrics, IU Health, IU Health Physicians, IU School of Nursing, IU School of Medicine Department of Biostatistics and Health Data Science.? https://lnkd.in/g6Sx7QYZ